Endothelial Cell Participation in Inflammatory Reaction #MMPMID34199319
Wautier JL; Wautier MP
Int J Mol Sci 2021[Jun]; 22 (12): ä PMID34199319show ga
Inflammation is an old concept that has started to be considered as an important factor in infection and chronic diseases. The role of leukocytes, the plasmatic components, then of the mediators such as prostaglandins, cytokines, and, in recent decades, of the endothelium has completed the concept of the inflammation process. The function of the endothelium appeared to be crucial as a regulator or the initiator of the inflammatory process. Culture of human endothelial cells and experimental systems made it possible to define the molecular basis of inflammation in vascular diseases, in diabetes mellitus, atherosclerosis, vasculitis and thromboembolic complications. Advanced glycation end product receptor (RAGE), present on endothelial cells (ECs) and monocytes, participates in the activation of these cells in inflammatory conditions. Inflammasome is a cytosolic multiprotein that controls the response to diverse microorganisms. It is positively regulated by stimulator of interferon response CGAMP interactor-1 (STING1). Angiogenesis and thrombotic events are dysregulated during inflammation. ECs appear to be a protector, but also a possible initiator of thrombosis.
|Atherosclerosis/metabolism/*pathology[MESH]
|Endothelium, Vascular/cytology/*metabolism[MESH]
|Humans[MESH]
|Inflammasomes/metabolism[MESH]
|Membrane Proteins/metabolism[MESH]
|Neovascularization, Physiologic[MESH]
|Nitric Oxide/metabolism[MESH]
|Receptor for Advanced Glycation End Products/metabolism[MESH]
free
free
free
Int+J+Mol+Sci 2021 ; 22 (12): ä
